RxDoctor Payments Data

Ahmed Siddiqi, DO

Adult Reconstructive Orthopaedic Surgery · Manasquan, NJNPI 1073938460

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Stryker accounts for 87.5% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $30,352, more than ten times the $1,226 reported in 2019.

$38,959in general payments, 2019–2025

Across 175 payments — averaging $222.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$34K
  • Medical Device Business Services, Inc.$1K
  • Smith+Nephew$1K
  • Zimmer Biomet$374
  • Think Surgical, Inc.$230
  • Medtronic$175
  • plus $1K from 22 others

What the payments were for

  • Consulting fees$22,45958%
  • Travel & lodging$9,50824%
  • Food & beverage$6,99218%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,959 in reported general payments places this provider in the 65th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.

See all adult reconstructive orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$515,636
Medicare patients
621
Services billed
8,498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$13,471
Tranexamic Acid75$3,785
Doxycycline Hyclate241$2,291
Ondansetron OdtOndansetron242$2,221
Cefadroxil254$2,099
Famotidine242$2,064
Meloxicam637$1,940
Methocarbamol168$1,512
Pregabalin211$1,430
Diclofenac Sodium ErDiclofenac Sodium43$1,402
Mupirocin233$1,401
Methylprednisolone196$1,199
Dexamethasone351$1,124
Oxycodone Hcl262$999
Celecoxib31$586

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Manasquan

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →